NeueHealth (NEUE) vs. The Competition Head to Head Review

NeueHealth (NYSE:NEUE) is one of 3 public companies in the “Healthcare Plans” industry, but how does it contrast to its rivals? We will compare NeueHealth to similar companies based on the strength of its valuation, risk, analyst recommendations, dividends, profitability, earnings and institutional ownership.

Valuation & Earnings

This table compares NeueHealth and its rivals gross revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
NeueHealth	$1.16 billion	-$1.15 billion	-0.04
NeueHealth Competitors	$65.48 billion	$1.34 billion	-0.59

NeueHealth’s rivals have higher revenue and earnings than NeueHealth. NeueHealth is trading at a higher price-to-earnings ratio than its rivals, indicating that it is currently more expensive than other companies in its industry.

Volatility and Risk

NeueHealth has a beta of 0.85, indicating that its stock price is 15% less volatile than the S&P 500. Comparatively, NeueHealth’s rivals have a beta of 0.53, indicating that their average stock price is 47% less volatile than the S&P 500.

Institutional and Insider Ownership

63.9% of NeueHealth shares are owned by institutional investors. Comparatively, 75.4% of shares of all “Healthcare Plans” companies are owned by institutional investors. 64.3% of NeueHealth shares are owned by company insiders. Comparatively, 32.5% of shares of all “Healthcare Plans” companies are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Profitability

This table compares NeueHealth and its rivals’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
NeueHealth	-71.23%	N/A	-1.21%
NeueHealth Competitors	0.19%	5.05%	2.04%

Analyst Ratings

This is a breakdown of recent ratings and target prices for NeueHealth and its rivals, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
NeueHealth	0	1	0	0	2.00
NeueHealth Competitors	3	105	337	18	2.80

NeueHealth currently has a consensus price target of $8.00, suggesting a potential upside of 30.08%. As a group, “Healthcare Plans” companies have a potential upside of 2.68%. Given NeueHealth’s higher possible upside, analysts clearly believe NeueHealth is more favorable than its rivals.

Summary

NeueHealth rivals beat NeueHealth on 9 of the 13 factors compared.

About NeueHealth

NeueHealth, Inc., a healthcare company, provides various healthcare services for health consumers, providers, and payors in the United States. It operates through two segments: NeueCare and NeueSolutions. The NeueCare segment delivers healthcare services to ACA marketplace, medicare, and medicaid through owned and affiliated clinics. It operates risk-bearing clinics under the Centrum Health, AssociatesMD, and Premier Medical Associates brand names. The company also offers integrated system care solution, such as embedded pharmacy, laboratory, radiology, and population health focused specialty services; and chronic care management, transitions of care, and referral management services. The NeueSolutions segment enables providers and medical groups to succeed in performance-based arrangements; and participates in the centers for healthcare access to medicare beneficiaries. The company was formerly known as Bright Health Group, Inc. and changed its name to NeueHealth, Inc. in January 2024. NeueHealth, Inc. was incorporated in 2015 and is headquartered in Doral, Florida.